Assiut University
Asyut, Egypt
NCT Number: NCT03032770
Placenta accreta is a substantially life threatening condition and one of the causes of maternal morbidity and mortality in the world. According to study done in United Kingdom, The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall and 577 per 10,000 in women with both a previous cesarean delivery and placenta previa. in a tertiary south Italian center, The incidence increased from 0.12% during the 1970s, to 0.31% during the 2000s.While in United States of America, the prevalence of placenta accreta was 3.7 per 1000 deliveries.
Looking for future studies?
Notify MeFemale
Observational
Asyut, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a) Cases far away from our hospital and expected to be lost to be followed. b) Pregnant women who will refuse to Participate
-
the eligible participants will be searched for signs suggestive of placenta accreta; low implantation of the gestational sac (<4cm from the external os), presence of placental lakes, Disruption of placental-myometrial interface and trophoblast overlapping a uterine scar by 2 dimensional transvaginal ultrasound and Intraplacental dilated vessels, turbulent blood flows and greatly increased periplacental vascularity by Doppler ultrasound by level II sonographer and co-investigator under his supervision using ultrasound device.
Time frame: duration of pregnancy
Assiut University
Other
Early Prediction of Placenta Accreta by 2 Dimensional Transvaginal Ultrasound and Color Doppler
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07662187
Conservative Management, Female Urogenital Diseases and Pregnancy Complications
Sohag, Egypt
View Trial DetailsNCT02729974
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
View Trial DetailsNCT02302573
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Poitiers, France
View Trial DetailsNCT06220760
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Asyut, Asyut Governorate, Egypt
View Trial Details